Planned discontinuation — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14)Nov 7, 2025
In shortage now — Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4)Jul 24, 2017
month 110 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)Jul 24, 2017
month 110 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5)Jul 24, 2017
month 110 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)Jul 24, 2017
month 110 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)Jul 24, 2017
month 110 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)Mar 1, 2017
Other
month 115 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)Mar 1, 2017
Other
month 115 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)Mar 1, 2017
month 115 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35)Mar 1, 2017
Other
month 115 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14)Mar 1, 2017
Discontinuation of the manufacture of the drug
month 115 — 6× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months